Why waste time running around when you can find everything in one place
CMS intends to provide technical instructions separate from this rulemaking to manufacturers of Part D rebatable drugs regarding how to access Rebate Reports and how to receive notifications alerting the manufacturer when information is available
We also anticipate initiating analysis of the impact of improper payments on an ACO's payment determination upon learning of improper payments originating inside the ACO that may potentially impact Shared Savings Program calculations, and may reopen the ACO's payment determination, as needed, to address program integrity concerns
We are considering whether alternatives to the active engagement approach for the measures under the Public Health and Clinical Data Exchange objective could better allow us to assess MIPS eligible clinician's performance, meet the data needs of PHAs, and ultimately allow us to incentivize increased performance in these areas
For the MIPS quality measures available in the APP quality measure set and APP Plus quality measure set for the CY 2025 performance period, we refer readers to section IV.A.4.c.(1) and section IV.A.4.c.(3) of this proposed rule